Related Experiment Video
Updated: Aug 8, 2026

Detection and Isolation of Viable Mouse IL-17-Secreting T Cells
Published on: December 18, 2008
Isolation and sequence analysis of serine protease cDNAs from mouse cytolytic T lymphocytes
1Laboratory of Molecular Genetics, Guthrie Research Institute, Sayre, Pennsylvania 18840.
Abstract:
Three new cDNA clones (designated MCSP-1, MCSP-2, and MCSP-3) encoding mouse serine proteases were isolated from cloned cytolytic T lymphocytes (CTL) by a modified differential screening procedure. The putative mature proteins of MCSP-2 and MCSP-3 are each composed of 228 amino acids with molecular weights of 25,477 and 25,360, respectively. NH2-terminal amino acids of MCSP-2- and MCSP-3-predicted proteins were identical to those reported for granzyme E and F, respectively. The third species, MCSP-1, was closely related to the two other cDNA species but approximately 30 amino acids equivalents of the NH2-terminal portion of the cDNA were not cloned. The amino acids forming the active sites of serine proteases were well conserved among the three predicted proteins. The active site pocket residue positioned six residues before the active-site Ser184 is alanine in MCSP-1, threonine in MCSP-2, and serine in MCSP-3, indicating that both MCSP-2 and MCSP-3 may have chymotrypsin-like specificity. There are three potential asparagine-linked glycosylation sites in MCSP-1 and MCSP-3, and four in MCSP-2-deduced amino acid sequences. Amino acid comparison of MCSP-1 with four other reported serine proteases whose active site pocket residue is alanine revealed that MCSP-1 was substantially different from the other molecules, indicating that MCSP-1 may be a new member of mouse T cell serine protease family. Antibodies made against a MCSP-1 lacZ gene fusion protein stain granules of CTL and react on immunoblots with two distinct granule protein bands of 29 and 35-40 kD. Only the 35-kD species labels with [3H]DFP. Since a protease cascade may play a key role in cytolytic lymphocyte activation, our isolation of cDNAs representative of unique serine esterases should help to investigate such a cascade process.
Insights
Researchers identified three new mouse serine proteases (MCSP-1, MCSP-2, MCSP-3) from cytolytic T lymphocytes. MCSP-1 may represent a novel serine protease family member, aiding research into protease cascades in immune cell activation.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Cytolytic T lymphocytes (CTL) play a crucial role in adaptive immunity.
- Serine proteases are implicated in immune cell activation and cytotoxic pathways.
- Understanding the diversity of serine proteases in CTLs is essential for elucidating immune mechanisms.
Purpose of the Study:
- To identify and characterize novel serine protease genes expressed in mouse CTLs.
- To investigate the structural and potential functional properties of these newly identified proteases.
- To explore the role of these serine proteases in immune response pathways.
Main Methods:
- Modified differential screening of cDNA libraries from cloned CTLs.
- Nucleotide sequencing and amino acid prediction of isolated cDNA clones.
- Bioinformatic analysis including sequence comparison and identification of conserved active sites.
- Antibody-based detection and characterization of expressed proteins.
Main Results:
- Three novel cDNA clones, MCSP-1, MCSP-2, and MCSP-3, encoding mouse serine proteases were isolated.
- MCSP-2 and MCSP-3 show high homology to granzymes E and F, respectively.
- MCSP-1 exhibits unique characteristics, suggesting it is a new member of the mouse T cell serine protease family.
- Antibodies confirmed the presence of MCSP-1 in CTL granules, with distinct protein forms detected.
Conclusions:
- The identification of MCSP-1, MCSP-2, and MCSP-3 expands the known repertoire of serine proteases in CTLs.
- MCSP-1's unique features warrant further investigation into its specific function and role.
- These findings provide valuable tools for studying protease cascades involved in CTL activation and function.

